Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Achieve Life Sciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get ACHV alerts

About Lucian Iancovici

Lucian Iancovici is recorded as Chairman at Achieve Life Sciences, Inc. (ACHV) since June 8, 2026, Board Member at Achieve Life Sciences, Inc. (ACHV) since January 1, 2026 and Board Member at Rallybio Corp (RLYB) since January 1, 2020. The newest filing on record that lists Lucian Iancovici as Board Member at Achieve Life Sciences, Inc. (ACHV) is dated June 8, 2026. The newest filing on record that lists Lucian Iancovici as Board Member at Rallybio Corp (RLYB) is dated April 7, 2025. Lucian Iancovici was last confirmed as Board Member at Sionna Therapeutics, Inc. (SION) in a filing dated April 29, 2025. Achieve Life Sciences, Inc. reported in an 8-K filed May 12, 2026 that Lucian Iancovici was appointed Chair of the Board, effective June 8, 2026. Achieve Life Sciences, Inc. reported in an 8-K filed April 16, 2026 that Lucian Iancovici was appointed director, effective April 17, 2026. Ceribell, Inc. reported in an 8-K filed January 2, 2026 that Lucian Iancovici resigned as member of the Board of Directors, effective December 31, 2025. Achieve Life Sciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Rallybio Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Achieve Life Sciences, Inc. includes Andrew D. Goldberg (CEO and Board Member), Andrew Goldberg (CEO and Board Member), John Bencich (CEO) and 7 others.

“Following Mr. King’s resignation, Lucian Iancovici, MD, was appointed as Chair of the Board, effective as of June 8, 2026.”
Achieve Life Sciences, Inc. Form 8-K, filed May 12, 2026 · Read the filing
“on April 15, 2026, the Board appointed each of Lucian Iancovici and Aaron Royston (together, the “Initial Incoming Directors”), as designated by TPG Life Sciences Innovations and venBio Partners, respectively, to serve as a director of the Company, effective April 17, 2026.”
Achieve Life Sciences, Inc. Form 8-K, filed April 16, 2026 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2020-01-01–present

Leadership on record at Achieve Life Sciences, Inc.

Leadership on record at Rallybio Corp

Recent activity